Pulsed vs. Continuous Red Light Therapy: Which Is Better

Pulsed red light therapy is not automatically more advanced than continuous-wave therapy. Continuous wave (CW) and pulsed wave (PW) describe how a device delivers light over time, but neither mode is universally superior. The result depends on the complete exposure protocol: wavelength, measured irradiance at the treatment plane, exposure time, beam area and uniformity, pulse width, duty cycle, treatment geometry, anatomical target, and treatment schedule.

That distinction matters because studies often compare different wavelengths, sources, peak powers, average powers, or treatment times. A result attributed to "pulsing" may therefore reflect a dose difference rather than a biological advantage of the pulse pattern itself.

This guide explains how CW and PW differ, how to calculate incident radiant exposure correctly, what direct comparisons have actually found, and which device specifications must be verified before pulse settings can be interpreted responsibly.

What changes when a device switches from continuous to pulsed mode?

Pulsed vs continuous red light therapy panel beam and waveform diagram

In an ideal CW system, optical output remains approximately constant throughout the exposure. In a PW system, the output rises and falls according to a defined waveform. A complete pulse description requires more than frequency alone.

Real LED drivers may contain high-frequency switching, ripple, or pulse-width modulation even when the user interface says "continuous." Conversely, the off period in a nominal pulse mode may not fall completely to zero. The operating mode should therefore be confirmed with optical measurements rather than inferred only from the display.

Red and near-infrared photobiomodulation may involve photon interactions with mitochondrial chromophores, including cytochrome c oxidase, together with changes in nitric oxide, reactive oxygen species, calcium signaling, and other light-sensitive pathways. These mechanisms remain an active research area. It is more accurate to say that CW and PW expose many of the same candidate photoreceptors under different temporal conditions than to claim that one settled mechanism explains every response.

Dose calculation: use average irradiance, not an ambiguous rated value

Red light therapy measurement plane with irradiance and pulse labels

For a constant or time-averaged irradiance, incident radiant exposure is calculated as:

Radiant exposure (J/cm²) = Irradiance (mW/cm²) × Time (seconds) ÷ 1,000

For a changing waveform, the rigorous calculation is the integral of irradiance over time. For an ideal rectangular pulse train whose off-state output is zero:

Average irradiance = Peak irradiance × Duty cycle

Duty cycle = Pulse width × Pulse frequency

The duty-cycle equation assumes one rectangular pulse per cycle and consistent units. A 10 Hz setting with a 10% duty cycle has an on-time of 10 milliseconds per 100-millisecond cycle; the same 10 Hz setting at a 90% duty cycle has an on-time of 90 milliseconds. Those exposures cannot be described adequately as merely "10 Hz."

Consider a hypothetical device measured at 40 mW/cm² during the on phase. Ten minutes of CW exposure produces an incident radiant exposure of:

40 × 600 ÷ 1,000 = 24 J/cm²

If the device uses ideal 50% square-wave pulsing with the same 40 mW/cm² on-phase irradiance, its average irradiance is 20 mW/cm² and the same ten minutes produces:

20 × 600 ÷ 1,000 = 12 J/cm²

Extending the pulsed exposure to 20 minutes would match the CW example's incident radiant exposure at the measurement plane. It would not, by itself, prove equal tissue dose, temperature, cellular response, or clinical outcome. Treatment time and irradiance are not always biologically interchangeable.

Before comparing modes, verify all of the following:

1. Measurement location: irradiance at the actual working distance and treatment plane, not at the LED lens or an unspecified distance.
2. Value type: whether the reported PW value is peak irradiance, time-averaged irradiance, or a center-point maximum.
3. Pulse definition: frequency, pulse width, duty cycle, waveform, rise/fall time, and off-state output.
4. Spatial distribution: average, minimum, maximum, and uniformity across a stated grid rather than a single hotspot.
5. Operating conditions: enabled wavelength channels, intensity setting, warm-up time, ambient conditions, and output stability during a full session.
6. Measurement method: instrument model, spectral range, calibration status, geometry, and measurement uncertainty.

Electrical input power, nominal LED wattage, and optical irradiance are different quantities and must not be substituted for one another.

What direct CW-versus-PW research actually shows

Continuous versus pulsed photobiomodulation evidence comparison

The widely cited review by Hashmi et al. examined 33 publications available through 2010. It found some evidence that pulsed light can differ from CW, but it did not identify a universally superior mode or optimal frequency. The included studies varied in wavelength, source type, pulse structure, dose, species, and outcome. Only a small subset offered a close CW-versus-PW comparison.

The frequency findings were also widely dispersed. In the reviewed wound-healing literature, tested frequencies extended from approximately 2.5 Hz to 20,000 Hz. Pain studies reported different responses at 4, 10, 60, 200, 600, and 8,000 Hz, while animal stroke studies tested 100 and 1,000 Hz.

Later studies add useful examples but do not establish a universal rule:

• A 2016 rat wound-healing study compared 810 nm CW with 10 Hz and 100 Hz PW and reported the strongest result in its 10 Hz group. This was a specific preclinical model, not a general prescription for human wounds or consumer panels.
• A 2023 randomized study in 56 healthy young adults tested transcranial PBM at 660 or 850 nm using CW, 40 Hz PW, 100 Hz PW, or sham conditions. Some vigilance, memory, sleepiness, and EEG measures improved in pulsed groups under the study conditions. The participants were healthy, the sample was divided across multiple groups, and the outcomes do not establish a treatment frequency for neurological disease.
• A 2025 Journal of Biophotonics paper modeled CW and PW delivery from a high-intensity 1064 nm laser to a human knee model. Its thermal and fluence findings apply to the modeled laser parameters; it was not a clinical trial, a sequential CW-plus-burst protocol, or a validation of large LED panels.

The defensible conclusion is not that one mode wins. It is that pulse effects, when present, are specific to the wavelength, source, peak and average output, pulse structure, target, and experimental design.

Why frequency alone is not a treatment protocol

A label such as "10 Hz," "40 Hz," or "1,000 Hz" omits most of the information needed to reproduce an exposure. At minimum, a PW protocol should report:

• wavelength and spectral bandwidth;
• light source type and beam geometry;
• peak and average irradiance at the treatment plane;
• pulse repetition frequency;
• pulse width and duty cycle;
• waveform and off-state output;
• illuminated area and spatial uniformity;
• exposure time and total incident radiant exposure;
• contact or non-contact application technique;
• treatment number and interval.

Laser and LED results also require careful separation. Lasers may have narrower spectral bandwidths, smaller or more controlled beam areas, greater coherence, and pulse structures with peak powers that a large LED panel cannot reproduce. Matching frequency and nominal J/cm² does not make two devices equivalent.

Does pulsing improve penetration or reduce heat?

Pulsing does not inherently change the tissue's wavelength-dependent absorption and scattering coefficients. Under approximately linear optical conditions, modulation alone does not make photons ignore normal tissue optics. Apparent penetration advantages can arise when a pulsed system is allowed to use a higher on-phase peak output while remaining within a surface-temperature or average-power constraint. That is a system-level tradeoff, not a universal property of a frequency.

Pulsing can reduce average power and short-term heating when peak irradiance and exposure time remain fixed. If the session is extended to restore the same incident radiant exposure, the thermal result depends on pulse width, duty cycle, frequency, beam area, wavelength, tissue perfusion, cooling, and the relationship between pulse timing and tissue thermal relaxation. It must be measured for the actual device and protocol.

For that reason, universal rules such as "use CW below 30 mW/cm²" or "use PW above 100 mW/cm²" are not evidence-based. Irradiance alone cannot determine the correct mode, and a lower frequency is not automatically cooler or more effective.

A practical framework for choosing CW or PW

1. When following a published protocol, match the full protocol. Do not copy only the wavelength or frequency while changing the source, average irradiance, duty cycle, geometry, or schedule.
2. When no mode-specific evidence exists, CW is often easier to characterize. This is a dosimetry advantage, not proof of superior clinical efficacy.
3. Use PW only when its complete parameters are available. A frequency selector without disclosed duty cycle, pulse width, and measured average output is not enough for reproducible dosing.
4. Treat thermal management as a measured engineering question. Use stabilized output and temperature data rather than an arbitrary irradiance threshold.
5. Separate product settings from clinical prescriptions. A wide adjustment range provides engineering flexibility; it does not mean every setting has a validated biological purpose.

Verification setup for a pulse-capable red light therapy panel

Applying the framework to a published specification

As a real-world specification-reading example, the REDDOT LED RDPRO1500-FS8 Ultra is published with 300 LEDs, eight independently adjustable wavelength channels at 590, 630, 660, 670, 810, 830, 850, and 1060 nm, manufacturer-stated irradiance above 196 mW/cm² at 15 cm, and an adjustable 0–9,999 Hz pulse function for the NIR channels. These specifications make the panel relevant to a CW/PW discussion, but they do not identify an optimal treatment frequency. A buyer or protocol designer should still request the enabled-channel test configuration, spatial irradiance map, peak-versus-average measurement basis, duty-cycle and pulse-width behavior, stabilized output, temperature data, and model-specific safety documentation.

Hardware verification: confirm the waveform before interpreting biology

Pulse accuracy should be demonstrated by measurement, not inferred from the number of factory inspection steps or from a quality-system certificate.

A useful engineering verification package includes:

1. Spectral output: peak wavelength, full width at half maximum, and channel-level spectral irradiance.
2. Treatment-plane irradiance: average, minimum, maximum, and uniformity at specified distances.
3. Temporal waveform: optical detector and oscilloscope traces showing frequency, pulse width, duty cycle, peak level, off-state level, and rise/fall time.
4. Thermal stability: optical output and enclosure/treatment-plane temperature after warm-up and throughout the maximum intended operating time.
5. Setting repeatability: repeated measurements across units, production lots, intensity levels, and wavelength combinations.
6. Measurement traceability: calibrated instruments, documented geometry, uncertainty, and test dates.
7. Configuration traceability: exact model, firmware, driver board, LED bin, lens, and power-supply revision.

ISO 13485 and MDSAP address quality-management and regulatory processes. They can support controlled production, but a certificate alone does not prove the pulse accuracy, irradiance uniformity, or output stability of a particular model. Likewise, an ETL or other NRTL listing demonstrates conformity to the specific safety standards named in the listing; it should not be presented as an efficacy certificate or optical-performance report unless those properties are explicitly within the evaluated scope.

Regulatory and photobiological-safety context

Optical safety and medical-device documentation beside an LED panel

Medical-device classification is driven by intended purpose and jurisdiction-specific risk rules. CW or PW is not normally a classification category by itself, but operating parameters may affect the risk analysis. For example, rules for active therapeutic devices can consider the nature, density, and site of applied energy. A higher peak output or a newly added pulse configuration may therefore require updated verification, risk controls, labeling, or regulatory assessment even when the product family remains the same.

IEC 62471 provides a framework for assessing photobiological hazards from incoherent broadband sources, including LEDs. The evaluation is not based on one unweighted irradiance number. It can involve wavelength-weighted irradiance or radiance, apparent source size, distance, exposure duration, and operating configuration. For non-laser medical light-source equipment intended to create therapeutic, diagnostic, monitoring, cosmetic, or aesthetic effects, IEC 60601-2-57:2023 may also be relevant. Home light-therapy equipment may fall within additional requirements such as IEC 60601-2-83, depending on intended use and market.

Regulatory and conformity terms should remain precise:

• CE marking indicates conformity with the EU legislation applicable to the product; it is not limited to EMC and is not an EU "approval" badge.
• FCC equipment authorization or a Supplier's Declaration of Conformity addresses applicable US radio-frequency rules; it does not establish photobiological safety or therapeutic efficacy.
• FDA establishment registration and device listing do not denote FDA approval, clearance, certification, or authorization. A device's US pathway must be described separately and accurately.
• An IEC test report applies to the tested model, configuration, conditions, and standard edition. It should not be generalized to unrelated models or every possible operating mode.

User safety considerations

Users should follow the exact model's instructions for use, operating distance, session limits, eye-protection requirements, and contraindications. Direct viewing of a high-output red or NIR source should not be assumed safe merely because the light is non-ionizing or because NIR is invisible.

Photosensitizing medicines and medical conditions can change an individual's response to light. Visible flashing light can also trigger seizures in some people with photosensitive epilepsy; anyone with a known history of visually triggered seizures should avoid self-selecting pulsed modes and seek qualified medical guidance.

There is no universal rule that persistent redness for a specific number of minutes proves "overdosing," nor is there one rest-day schedule that applies to every device and indication. Unexpected or persistent redness, pain, burning, eye symptoms, headache, or neurological symptoms are reasons to stop the exposure and obtain appropriate professional advice. This article is an educational dosimetry and device-evaluation guide, not an individualized treatment prescription.

Key takeaways

• Neither CW nor PW is universally superior.
• Incident radiant exposure must be calculated from measured time-averaged irradiance; peak irradiance must not be mistaken for an average value.
• Frequency alone is not a reproducible pulse protocol.
• Matching J/cm² does not guarantee equal tissue exposure, temperature, or biological response.
• Pulsing may offer a thermal or peak-output engineering advantage in a specific system, but that advantage must be demonstrated under the actual operating conditions.
• Device certificates and registrations do not replace model-specific optical, waveform, thermal, and safety measurements.

FAQ

Is pulsed red light therapy better than continuous red light therapy?

Not as a general rule. Some animal, laboratory, modeling, and small human studies have reported parameter-specific PW advantages, while other comparisons favor CW or find no meaningful difference. The appropriate conclusion is application-specific uncertainty, not universal PW superiority.

Should duty cycle always be multiplied by the device's listed irradiance?

No. Multiply peak on-phase irradiance by duty cycle only when the listed or measured value is truly the peak, the waveform assumptions are valid, and off-state output is approximately zero. If the device already reports time-averaged irradiance in pulse mode, multiplying by duty cycle again would understate the exposure.

Does a pulsed mode send light deeper into tissue?

Not inherently. Wavelength, tissue optical properties, beam geometry, and incident energy determine light distribution. A pulsed system may use a higher peak output under an average-power or temperature constraint, but that is different from frequency itself changing tissue optics.

What pulse specifications should a buyer request?

Request frequency, pulse width, duty cycle, optical waveform, peak and time-averaged irradiance, off-state output, active wavelength channels, measurement distance, spatial uniformity, warm-up behavior, and stabilized output. The report should identify the exact model, settings, instrument, calibration status, and uncertainty.

What is the safest default when a device does not disclose its pulse parameters?

Do not build a dose calculation around an undisclosed pulse mode. Use only a fully characterized operating mode and follow the model-specific instructions. For research or professional protocols, independently verify the waveform and treatment-plane output before use.

References

• Hashmi JT, Huang YY, Sharma SK, et al. "Effect of Pulsing in Low-Level Light Therapy." Lasers in Surgery and Medicine. 2010;42(6):450–466. DOI and full text
• Hamblin MR. "Mechanisms and Applications of the Anti-Inflammatory Effects of Photobiomodulation." AIMS Biophysics. 2017;4(3):337–361. DOI and full text
• Jenkins PA, Carroll JD. "How to Report Low-Level Laser Therapy/Photomedicine Dose and Beam Parameters in Clinical and Laboratory Studies." Photomedicine and Laser Surgery. 2011;29(12):785–787. PubMed
• Keshri GK, Gupta A, Yadav A, Sharma SK, Singh SB. "Photobiomodulation with Pulsed and Continuous Wave Near-Infrared Laser…" PLOS ONE. 2016;11(11):e0166705. Full text
• Tang L, Jiang H, Sun M, Liu M. "Pulsed Transcranial Photobiomodulation Generates Distinct Beneficial Neurocognitive Effects Compared with Continuous Wave Transcranial Light." Lasers in Medical Science. 2023;38:203. PubMed
• Chaki C, De Taboada L, Tse KM. "Comparative Analysis of Pulsed and Continuous Wave Modes in High-Intensity Laser Light Therapy." Journal of Biophotonics. 2025;18(7):e202400164. PubMed
• International Electrotechnical Commission. IEC 62471:2006—Photobiological Safety of Lamps and Lamp Systems
• International Electrotechnical Commission. IEC 60601-2-57:2023—Non-Laser Light Source Equipment
• U.S. Food and Drug Administration. Important Reminders About Registration and Listing
• Therapeutic Goods Administration. Classifying Active Medical Devices in Australia
• European Commission. CE Marking
• Epilepsy Foundation. Photosensitivity and Seizures